GENI Stock Analysis: Genius Sports | NYSE
Internet Content & Information | NYSE, USA | Market Cap: 1.730m USD | 12M Return: -36% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 32.8M
Qual. Beats: 0
Rev. Trend: 99.2%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Genius Sports Limited (NYSE: GENI) is a London-headquartered B2B technology company serving the global sports, sports betting, and sports media industries. The company operates across three core pillars: sports data and technology infrastructure (live optical tracking, event data feeds, and video distribution for leagues), betting-related services (pre-game and in-game odds feeds, risk management tools, and live streaming for sportsbooks), and integrity and fan engagement products (fraud monitoring, educational services, and tools such as BetVision and FanHub for personalized viewing and digital advertising). Genius Sports sells its products primarily to sports leagues, sportsbook operators, and media companies rather than directly to consumers, positioning it as an infrastructure provider at the intersection of sports content and regulated sports betting markets.
Founded in 2001 and listed on the NYSE following its April 2021 IPO (formerly known as Genius Sports Group Limited), the company is classified under the Communication Services sector and the Interactive Media & Services sub-industry. Its revenue model is largely driven by long-term data and technology partnerships with major sports leagues, supplemented by betting-related services tied to the volume of sports wagering activity worldwide.
- US sports betting legalization accelerates technology and data demand
- Exclusive league partnerships like NFL data boost margins
- Sportradar competition pressures pricing and market share
| Net Income: -158.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.54 > 1.0 |
| NWC/Revenue: 22.71% < 20% (prev 42.21%; Δ -19.49% < -1%) |
| CFO/TA 0.05 > 3% & CFO 54.3m > Net Income -158.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (269.4m) vs 12m ago 8.43% < -2% |
| Gross Margin: 22.65% > 18% (prev 28.23%; Δ -5.58% > 0.5%) |
| Asset Turnover: 74.15% > 50% (prev 59.02%; Δ 15.13% > 0%) |
| Interest Coverage Ratio: -31.5k > 6 (EBIT TTM -189.1m / Interest Expense TTM 6.00k) |
| A: 0.16 (Total Current Assets 436.0m - Total Current Liabilities 274.0m) / Total Assets 1.02b |
| B: -1.23 (Retained Earnings -1.25b / Total Assets 1.02b) |
| C: -0.20 (EBIT TTM -189.1m / Avg Total Assets 962.2m) |
| D: 2.15 (Book Value of Equity 695.1m / Total Liabilities 322.6m) |
| Altman-Z'' = -2.03 = D |
| DSRI: 1.07 (Receivables 173.6m/122.0m, Revenue 713.5m/535.2m) |
| GMI: 1.25 (GM 28.23% / 22.65%) |
| AQI: 0.97 (AQ_t 0.51 / AQ_t-1 0.52) |
| SGI: 1.33 (Revenue 713.5m / 535.2m) |
| TATA: -0.21 (NI -158.9m - CFO 54.3m) / TA 1.02b) |
| Beneish M = -2.55 (Cap -4..+1) = A |
As of July 15, 2026, the stock is trading at USD 6.61 with a total of 5,317,415 shares traded. Over the past week, the price has changed by -0.15%, over one month by -3.78%, over three months by +59.66% and over the past year by -35.95%.
Current recommended Stop Loss: 6.10 (which is 7.7% or 1.3 ATR below the current price).
Genius Sports has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy GENI.
- StrongBuy: 11
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10.2 | 54.2% |
P/E Forward = 56.8182
P/S = 2.4244
P/B = 2.473
Revenue TTM = 713.5m USD
EBIT TTM = -189.1m USD
EBITDA TTM = -113.4m USD
Long Term Debt = 25.5m USD (estimated: total debt 30.6m - short term 5.01m)
Short Term Debt = 5.01m USD (from shortTermDebt, last quarter)
Debt = 30.6m USD (from shortLongTermDebtTotal, last quarter) (leases 30.6m already included)
Net Debt = -166.9m USD (calculated: Debt 30.6m - CCE 197.4m)
Enterprise Value = 1.56b USD (1.73b + Debt 30.6m - CCE 197.4m)
Interest Coverage Ratio = -31.5k (Ebit TTM -189.1m / Interest Expense TTM 6.00k)
EV/FCF = 1000.0x (Enterprise Value 1.56b / FCF TTM 1.39m)
FCF Yield = 0.09% (FCF TTM 1.39m / Enterprise Value 1.56b)
FCF Margin = 0.20% (FCF TTM 1.39m / Revenue TTM 713.5m)
Net Margin = -22.27% (Net Income TTM -158.9m / Revenue TTM 713.5m)
Gross Margin = 22.65% ((Revenue TTM 713.5m - Cost of Revenue TTM 551.8m) / Revenue TTM)
Gross Margin QoQ = 22.87% (prev 28.45%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.56b / Total Assets 1.02b)
Interest Expense / Debt = 0.02% (Interest Expense 6.00k / Debt 30.6m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -149.4m (EBIT -189.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.59 (Total Current Assets 436.0m / Total Current Liabilities 274.0m)
Debt / Equity = 0.04 (Debt 30.6m / totalStockholderEquity, last quarter 695.1m)
Debt / EBITDA = 1.47 (negative EBITDA) (Net Debt -166.9m / EBITDA -113.4m)
Debt / FCF = -119.7 (out of range, set to none) (Net Debt -166.9m / FCF TTM 1.39m)
Total Stockholder Equity = 715.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -16.51% (Net Income -158.9m / Total Assets 1.02b)
RoE = -22.20% (Net Income TTM -158.9m / Total Stockholder Equity 715.6m)
RoCE = -25.52% (EBIT -189.1m / Capital Employed (Equity 715.6m + L.T.Debt 25.5m))
RoIC = -20.96% (negative operating profit) (NOPAT -149.4m / Invested Capital 713.0m)
WACC = 8.39% (E(1.73b)/V(1.76b) * Re(8.54%) + D(30.6m)/V(1.76b) * Rd(0.02%) * (1-Tc(0.21)))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.97 | Cagr: 7.80%
[DCF] Terminal Value 75.29% ; FCFF base≈1.39m ; Y1≈1.40m ; Y5≈1.48m
[DCF] Fair Price = 0.71 (EV 22.9m - Net Debt -166.9m = Equity 189.8m / Shares 267.3m; r=8.39% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.08 | # QB: 0
Revenue Correlation: 99.20 | Revenue CAGR: 26.29% | SUE: 4.0 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.04 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.19 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=0.52 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+240.8% | GrowthRev=+49.9%
EPS next Year (2027-12-31): EPS=0.97 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+86.5% | GrowthRev=+28.8%